Cost-Utility of Ranibizumab Versus Aflibercept for Treating Visual Impairment Due to Diabetic Macular Edema In Greece
| Autor: | Nikolaos Maniadakis, G Pantelopoulou, J. Relakis, Ronan Mahon, Georgia Kourlaba, M Kalogeropoulou, Olga Kousidou |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
business.industry Health Policy Visual impairment Diabetic macular edema Public Health Environmental and Occupational Health computer.software_genre Text mining Cost utility Ophthalmology medicine Data mining Ranibizumab medicine.symptom business computer Aflibercept medicine.drug |
| Zdroj: | Value in Health. 18:A423 |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/j.jval.2015.09.568 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect